advertisement

WGC-2027

Clinical Ophthalmology 96

Showing records 1 to 25 | Display all abstracts in Clinical Ophthalmology

73074 The Sensimed Triggerfish contact lens sensor: efficacy, safety, and patient perspectives
Dunbar GE
Clinical Ophthalmology 2017; 11: 875-882
72747 Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
Muñoz Negrete FJ
Clinical Ophthalmology 2017; 11: 557-566
73553 Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution
Lee D
Clinical Ophthalmology 2017; 11: 1273-1280
73089 Optic cup segmentation: type-II fuzzy thresholding approach and blood vessel extraction
Almazroa A
Clinical Ophthalmology 2017; 11: 841-854
72974 No differences in central corneal thickness between open-angle and pseudoexfoliation glaucoma patients
Ayala M
Clinical Ophthalmology 2017; 11: 733-738
73554 Agreement on the evaluation of glaucomatous optic nerve head findings by ophthalmology residents and a glaucoma specialist
Rossetto JD
Clinical Ophthalmology 2017; 11: 1281-1284
73349 Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
Pillunat LE
Clinical Ophthalmology 2017; 11: 1051-1064
73351 Ophthalmological findings in Cameroonian boxers
Kagmeni G
Clinical Ophthalmology 2017; 11: 1121-1126
72745 The efficacy of Alahmady ring implantation in the management of neovascular glaucoma
Alsmman AH
Clinical Ophthalmology 2017; 11: 541-548
73457 Ocular lubricant use in medically and surgically treated glaucoma: a retrospective longitudinal analysis
Iyer JV
Clinical Ophthalmology 2017; 11: 1191-1196
72913 Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss
Patodia Y
Clinical Ophthalmology 2017; 11: 683-687
73054 Goldmann tonometer error correcting prism: clinical evaluation
McCafferty S
Clinical Ophthalmology 2017; 11: 835-840
72973 Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension
Tamçelik N
Clinical Ophthalmology 2017; 11: 723-731
72912 Is high myopia a risk factor for visual field progression or disk hemorrhage in primary open-angle glaucoma?
Nitta K
Clinical Ophthalmology 2017; 11: 599-604
72736 Efficacy of two trabecular micro-bypass stents combined with topical travoprost in open-angle glaucoma not controlled on two preoperative medications: 3-year follow-up
Chang DF
Clinical Ophthalmology 2017; 11: 523-528
73352 Follow-up of the retinal nerve fiber layer thickness of diabetic patients type 2, as a predisposing factor for glaucoma compared to normal subjects
Takis A
Clinical Ophthalmology 2017; 11: 1135-1141
72983 Intersession test-retest variability of 10-2 MAIA microperimetry in fixation-threatening glaucoma
Wong EN
Clinical Ophthalmology 2017; 11: 745-752
72746 The SPARC-related modular calcium binding protein 2 (SMOC2) gene polymorphism in primary glaucoma: a case-control study
Al-Dabbagh N
Clinical Ophthalmology 2017; 11: 549-555
72610 Does the World Health Organization criterion adequately define glaucoma blindness?
Mokhles P
Clinical Ophthalmology 2017; 11: 473-480
73481 Effect of age, sex, and refractive errors on central corneal thickness measured by Oculus Pentacam(®)
Hashmani N
Clinical Ophthalmology 2017; 11: 1233-1238
73352 Follow-up of the retinal nerve fiber layer thickness of diabetic patients type 2, as a predisposing factor for glaucoma compared to normal subjects
Alonistiotis D
Clinical Ophthalmology 2017; 11: 1135-1141
72913 Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss
Golesic E
Clinical Ophthalmology 2017; 11: 683-687
73349 Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study
Erb C
Clinical Ophthalmology 2017; 11: 1051-1064
72610 Does the World Health Organization criterion adequately define glaucoma blindness?
Schouten J
Clinical Ophthalmology 2017; 11: 473-480
73089 Optic cup segmentation: type-II fuzzy thresholding approach and blood vessel extraction
Alodhayb S
Clinical Ophthalmology 2017; 11: 841-854

Issue 18-4

Change Issue


advertisement

WGA Rescources